Cooperation between somatic GOF PIK3CA and LOF p53 mutations have been well documented in breast cancer [19,125,132,133,134,135,136,137] and reproductive cancers in general [19,82,125,133,134,135,136,137,138,139,140,141,142]. This evidence concerns the gene TP53 and breast carcinoma.